Bill Text: TX HB740 | 2013-2014 | 83rd Legislature | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to newborn screening for critical congenital heart disease and other disorders.

Spectrum: Slight Partisan Bill (Republican 17-10)

Status: (Passed) 2013-06-14 - Effective on 9/1/13 [HB740 Detail]

Download: Texas-2013-HB740-Introduced.html
  83R5840 AED-F
 
  By: Crownover H.B. No. 740
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to newborn screening for congenital heart defects.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 33.001, Health and Safety Code, is
  amended by amending Subdivision (1) and adding Subdivision (1-a) to
  read as follows:
               (1)  "Congenital heart defect" means an abnormality in
  the structure and function of the heart that exists at birth.
               (1-a)  "Heritable disease" means an inherited disease
  that may result in mental or physical retardation or death.
         SECTION 2.  Section 33.011, Health and Safety Code, is
  amended by amending Subsections (a-1) and (c) and adding Subsection
  (d) to read as follows:
         (a-1)  Except as provided by this subsection and to the
  extent funding is available for the screening, the department shall
  require newborn screening tests to screen for disorders listed as
  core and secondary conditions in the December 2011 Recommended
  Uniform Screening Panel of the Secretary's Advisory Committee on
  Heritable Disorders in Newborns and Children [core panel and in the
  secondary targets of the uniform newborn screening panel
  recommended in the 2005 report by the American College of Medical
  Genetics entitled "Newborn Screening: Toward a Uniform Screening
  Panel and System"] or other recommendation [another report]
  determined by the department to provide more stringent newborn
  screening guidelines to protect the health and welfare of this
  state's newborns.  The department, with the advice of the Newborn
  Screening Advisory Committee, may require additional newborn
  screening tests under this subsection to screen for other disorders
  or conditions.  The department may exclude from the newborn
  screening tests required under this subsection screenings for
  galactose epimerase and galactokinase.
         (c)  Except as provided by Subsection (d), the [The]
  screening tests required by this section must be performed by the
  laboratory established by the department or by a laboratory
  approved by the department under Section 33.016.
         (d)  The department may authorize a screening test,
  including a screening for congenital heart defects, to be performed
  at a health care facility that provides newborn infant care and that
  complies with the test procedures and the standards of accuracy and
  precision required by the department for each screening test.
         SECTION 3.  Sections 33.0111(a), (b), and (f), Health and
  Safety Code, are amended to read as follows:
         (a)  The department shall develop a disclosure statement
  that clearly discloses to the parent, managing conservator, or
  guardian of a newborn child subjected to screening tests under
  Section 33.011:
               (1)  that the department, any health care facility
  authorized to perform the tests, or a laboratory established or
  approved by the department under Section 33.016 may retain for use
  by the department, health care facility, or laboratory genetic
  material used to conduct the newborn screening tests and discloses
  how the material is managed and used subject to this section and
  Sections 33.0112 and 33.018 [33.017]; [and]
               (2)  that reports, records, and information obtained by
  the department under this chapter that do not identify a child or
  the family of a child will not be released for public health
  research purposes under Section 33.018(c-1) [33.017(c-1)] unless a
  parent, managing conservator, or guardian of the child consents to
  disclosure; and
               (3)  that newborn screening blood spots and associated
  data are confidential under law and may only be used as described by
  Section 33.018 [33.017].
         (b)  The disclosure statement required by Subsection (a)
  must be included on the form developed by the department to inform
  parents about newborn screening.  The disclosure statement must:
               (1)   be in a format that allows a parent, managing
  conservator, or guardian of a newborn child to consent to
  disclosure under Section 33.018(c-1) [33.017(c-1)];
               (2)  include instructions on how to complete the
  portions of the form described by Subdivision (1);
               (3)  include the department's mailing address; and
               (4)  describe how a parent, managing conservator, or
  guardian of a newborn child may obtain information regarding
  consent through alternative sources.
         (f)  This section does not supersede the requirements
  imposed by Section 33.018 [33.017].
         SECTION 4.  Section 33.014(a), Health and Safety Code, is
  amended to read as follows:
         (a)  If, because of an analysis of a specimen submitted under
  Section 33.011, the department reasonably suspects that a newborn
  child may have phenylketonuria, another heritable disease,
  hypothyroidism, or another disorder for which the screening tests
  are required, the department shall notify the person who submits
  the specimen that the results are abnormal and provide the test
  results to that person.  The department may notify one or more of
  the following that the results of the analysis or of a screening
  test reported to the department under Section 33.015 are abnormal
  and recommend further testing when necessary:
               (1)  the physician attending the newborn child or the
  physician's designee;
               (2)  the person attending the delivery of the newborn
  child that was not attended by a physician;
               (3)  the parents of the newborn child;
               (4)  the health authority of the jurisdiction in which
  the newborn child was born or in which the child resides, if known;
  or
               (5)  physicians who are cooperating pediatric
  specialists for the program.
         SECTION 5.  Section 33.017(c), Health and Safety Code, is
  amended to read as follows:
         (c)  The advisory committee shall advise the department
  regarding strategic planning, policy, rules, and services related
  to newborn screening and additional newborn screening tests for
  each disorder included in the list described by Section
  33.011(a-1).
         SECTION 6.  Section 33.0111(g), Health and Safety Code, is
  repealed.
         SECTION 7.  As soon as practicable after the effective date
  of this Act, the Department of State Health Services shall
  implement the changes in law made by this Act to the newborn
  screening program under Chapter 33, Health and Safety Code.
         SECTION 8.  This Act takes effect September 1, 2013.
feedback